Abiopharma

News list

(99% Neutral) Brooklyn ImmunoTherapeutics, Inc. (BTX) Announces Executive Changes

Full text

News bot Oct. 2, 2025, 9:44 p.m.
📋 Brooklyn ImmunoTherapeutics, Inc. (BTX) - Executive Changes

Filing Date: 2022-08-05

Accepted: 2022-08-05 16:32:17

Event Type: Executive Changes
Event Details:
Brooklyn ImmunoTherapeutics Inc (the company was transformed Eterna Therapeutics (ERNA)) (BTX) Announces Executive and Board Changes Brooklyn ImmunoTherapeutics Inc (the company was transformed Eterna Therapeutics (ERNA)) (BTX) announced changes to its leadership team and board of directors. The position includes: Compensation Committee, The Committee. The change is effective as of August 1, 2022. Executive Changes Details:
Committee Assignments: Compensation Committee, The Committee
Effective Date: August 1, 2032
👥 Executive & Board Changes:
Committee Assignments: Compensation Committee, The Committee
Effective Dates: August 1, 2022, August 1, 2032, August 5, 2022
💼 Business Developments:
- Partnership: Not available
- Acquisition: Not available
- Licensing: Not available
- Regulatory Approval
- Executive Changes
Structured Data:
- Company Name: Brooklyn ImmunoTherapeutics Inc (the company was transformed Eterna Therapeutics (ERNA))
- CIK: 0000748592
- Ticker Symbol: BTX
- Period End Date: 2022-08-01
- Document Type: 8-K